Data gathered: June 2
AI Stock Analysis - ProPhase Labs (PRPH)
Analysis generated March 25, 2025. Powered by Chat GPT.
ProPhase Labs is a specialty healthcare company engaged in the research, development, manufacturing, and marketing of products that aid in healthcare maintenance and improvement. The company's portfolio ranges from clinical diagnostic services to over-the-counter remedies. The name ProPhase is synonymous with innovation in healthcare solutions, striving to meet the ongoing needs of consumers and healthcare partners alike.
Stock Alerts - ProPhase Labs (PRPH)
 |
ProPhase Labs | May 29 Price is up by 7.1% in the last 24h. |
|
ProPhase Labs | May 28 Price is down by -7.6% in the last 24h. |
|
ProPhase Labs | May 27 Price is up by 7.7% in the last 24h. |
|
ProPhase Labs | May 23 Price is up by 7.5% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for ProPhase Labs
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 53 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,168 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About ProPhase Labs
ProPhase Labs, Inc. is engaged in the research, development, manufacture, distribution, marketing, and sale of consumer health products and over-the-counter (OTC) dietary supplements in the United States. The company is headquartered in Garden City, New York.
| Price | $0.37 |
| Target Price | Sign up |
| Volume | 696,500 |
| Market Cap | $15M |
| Year Range | $0.24 - $2.47 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Financial Analysis: ProPhase Labs (NASDAQ:PRPH) and Carisma Therapeutics (NASDAQ:CARM)May 24 - ETF Daily News |
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ChallengesMay 21 - Yahoo Entertainment |
|
 |
ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call TranscriptMay 20 - SeekingAlpha |
 |
ProPhase Labs says CEO voluntarily agrees to defer salary by over two thirdsMay 20 - Thefly.com |
 |
Head-To-Head Contrast: Vectura Group (OTCMKTS:VEGPF) and ProPhase Labs (NASDAQ:PRPH)May 16 - ETF Daily News |
|
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLCMay 7 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | -2.5M | -3.4M | 920,000 | -34M | -14M | -0.133 |
| Q4 '24 | -2.5M | -3.4M | 920,000 | -34M | 0 | -1.590 |
| Q3 '24 | 3.1M | 3.3M | -170,000 | -6.6M | -5.4M | -0.350 |
| Q2 '24 | 2.5M | 3M | -480,000 | -6.2M | -6.1M | -0.330 |
| Q1 '24 | 3.6M | 4.1M | -430,000 | -6.3M | -6.5M | -0.070 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about ProPhase Labs (PRPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of ProPhase Labs?
The Market Cap of ProPhase Labs is $15M.
What is the current stock price of ProPhase Labs?
Currently, the price of one share of ProPhase Labs stock is $0.37.
How can I analyze the PRPH stock price chart for investment decisions?
The PRPH stock price chart above provides a comprehensive visual representation of ProPhase Labs' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ProPhase Labs shares. Our platform offers an up-to-date PRPH stock price chart, along with technical data analysis and alternative data insights.
Does PRPH offer dividends to its shareholders?
As of our latest update, ProPhase Labs (PRPH) does not offer dividends to its shareholders. Investors interested in ProPhase Labs should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ProPhase Labs?
Some of the similar stocks of ProPhase Labs are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.